This inventor holds 4 USPTO granted patents and 6 published patent applications. Top assignees: Scripps Research Institute, International Aids Vaccine Initiative, Vanderbilt University. Active years: 2021-2026.
Company Filing History:
3 out of 1,204 
2 out of 71 
1 out of 1,218 
Years Active: 2021-2026
Title: The Innovative Contributions of Xiaozhen Hu
Introduction
Xiaozhen Hu is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of immunology, particularly in the development of peptide vaccines. With a total of 4 patents, her work is recognized for its potential impact on public health.
Latest Patents
One of her latest patents is titled "Peptide Vaccine Based on a New Universal Influenza A Hemagglutinin Head Domain Epitope and Human Monoclonal Antibodies Binding Thereto." This invention focuses on immunogenic trimers and relates to PGT121-germline-targeting designs, trimer stabilization designs, and combinations of these two. Additionally, it includes trimers designed with modified surfaces that are beneficial for immunization regimens, as well as other trimer modifications and the development of trimer nanoparticles and methods for their production and use.
Career Highlights
Xiaozhen Hu has worked with esteemed organizations such as The Scripps Research Institute and the International Aids Vaccine Initiative. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Sergey V Menis and Dan Kulp. Their collaborative efforts have further advanced the research and development of innovative vaccine solutions.
Conclusion
Xiaozhen Hu's contributions to immunology and vaccine development highlight her role as a key inventor in the field. Her patents and collaborations reflect her commitment to advancing healthcare solutions.